MaxCyte
USEntry
2021
Hold
5yr
Status
Active
Who owns MaxCyte?
MaxCyte is currently owned by Vitruvian Partners through Vitruvian Investment Partnership IV (2020 vintage), since 2021. Across its history, MaxCyte has been through 2 private equity ownership periods, detailed in the timeline below.
Hand-verified · updated 2026-04-21
Most recent investor
Vitruvian PartnersVitruvian Investment Partnership IV · 2020 · Growth
2 ownership periods · full history below
Key facts
Ownership history
2 ownership periods · co-invest detected
Active
Co-invest · 2 holders · 2019 · present
Sofinnova PartnersActive
2019 · present(7yr) · Sofinnova Crossover Fund I · 2018 · VC
Vitruvian PartnersActive
2021 · present(5yr) · Vitruvian Investment Partnership IV · 2020 · Growth
More from Vitruvian Investment Partnership IV
Other portfolio companies in the same fund.
UK
SpainMore PE-backed in MedTech
Comparable medtech deals from other GPs.
Ireland
Denmark
FranceTrack MaxCyte
Save this record to your watchlist and pick up your research where you left off. No spam.
Get the full record on MaxCyte.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue